Interestingly, GPER KO mice exhibited greatly reduced age-associated renal fibrosis and kidney disease, likely through the regulation of Nox1, as observed in the heart and vasculature, suggesting a therapeutic role for GPER antagonists in chronic kidney disease (161, 211). Here, GPER1 is linked to renal fibrosis.